ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 21 filers reported holding ELIEM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,288 | +3.3% | 21,700 | +9.6% | 0.00% | – |
| Q2 2023 | $55,440 | -3.4% | 19,800 | 0.0% | 0.00% | – |
| Q1 2023 | $57,420 | -59.5% | 19,800 | -50.0% | 0.00% | – |
| Q4 2022 | $141,768 | +121.5% | 39,600 | +100.0% | 0.00% | – |
| Q3 2022 | $64,000 | +6.7% | 19,800 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -92.5% | 19,800 | -79.2% | 0.00% | – |
| Q1 2022 | $798,000 | -18.1% | 95,070 | +2.1% | 0.00% | – |
| Q4 2021 | $974,000 | -37.1% | 93,079 | +8.1% | 0.00% | – |
| Q3 2021 | $1,548,000 | – | 86,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,825,134 | $6,698,242 | 6.40% |
| RA Capital Management | 13,150,849 | $48,263,616 | 0.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 409,202 | $1,501,771 | 0.43% |
| Atom Investors LP | 75,651 | $277,639 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 551,942 | $2,025,627 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $197,698 | 0.01% |
| Chicago Partners Investment Group LLC | 18,179 | $61,936 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 30,607 | $112 | 0.00% |
| NORTHERN TRUST CORP | 11,494 | $42,183 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |